IGF1R and Alzheimer disease: These data might have several implications in AD and T2DM therapy, as the downregulation of cytoplasmic Hsp60 has been shown to contribute to IGF-IR ubiquitination [67] and the failure of insulin and IGF-I signaling is a common feature of diabetes and Alzheimer’s disease.